Genesys Biologics Private Limited - Company Profile

It is a life sciences private limited company based in Hyderabad, Telangana, India, established in 2014.

2014 Hyderabad, Telangana, India Active

Last Updated: December 22, 2025

About Genesys Biologics Private Limited

Genesys Biologics Private Limited, a active private limited company, was established on 18 November 2014 in Hyderabad, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24232TG2014PTC096432. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹2.33 Cr.

It upholds a compliant status. Employing 259 professional, Its leadership includes Kondrella Roopesh (Director), Tulasiramu Chatadi (Whole-Time Director), Venkata Krishna Rao Dasari (Whole-Time Director). Past directors included Kondrella Rakesh Rao, Tulasiramu Chatadi, Venkata Krishna Rao Dasari. It holds ₹58.50 Cr open charges and ₹61.28 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6-3-248/1/1/A, 4Th Floor Bhaskar Plaza, Road No1,Banjara Hills, Hyderabad, Telangana, 500034.

Company Details

CIN/LLPIN
U24232TG2014PTC096432
Registration Number
096432
Incorporation Date
18 November 2014
Authorized Capital
₹3.50 Cr
Paid-Up Capital
₹2.33 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.50 Cr as on 22-12-2025
Paid Up Capital ₹ 2.33 Cr as on 22-12-2025
Company Age 11 Year, 7 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 58.50 Cr as on 22-12-2025
Satisfied Charges ₹ 61.28 Cr as on 22-12-2025

Comprehensive Company Insights

Explore comprehensive insights into Genesys Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Genesys Biologics Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Kondrella Roopesh	Director	06 Feb 2015	Current
Tulasiramu Chatadi	Whole-Time Director	20 Aug 2015	Current
Venkata Krishna Rao Dasari	Whole-Time Director	20 Aug 2015	Current
Vamshider Joganpally Rao	Director	18 Nov 2014	Current
Yelma Venkat Reddy	Director	05 Feb 2015	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	06 Feb 2015	Past
Pramod Abcsdd	Additional Director	01 Sep 2015	Past
Pramod Abcsdd	Additional Director	01 Sep 2015	Past
Pramod Abcsdd	Additional Director	27 Oct 2022	Past
Pramod Abcsdd	Director	27 Oct 2022	Past
Pramod Abcsdd	Director	31 Jul 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genesys Biologics.

Genesys Biologics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genesys Biologics?

In 2023, Genesys Biologics had a public holding of 42.79%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹585,000,000.00

Satisfied Charges

₹612,750,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 58.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
21 Jul 2017	State Bank Of India	₹58.50 Cr	Open
03 Aug 2018	State Bank Of India	₹11.00 Cr	Satisfied
07 Sep 2017	Others	₹2.25 M	Satisfied
02 Apr 2017	State Bank Of India	₹36.00 Cr	Satisfied
29 Oct 2016	Others	₹5.50 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Genesys Biologics?

Genesys Biologics has a workforce of 259 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Genesys Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesys Biologics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genesys Biologics

Recent Activity within the Organization

Annual General Meeting

Progress on Genesys Biologics Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
28 Sep 2024
Charges

The activity A charge registered on 03 Aug 2018 via Charge ID 100200402 with State Bank Of India was fully satisfied on 30 May 2024. was completed.
30 May 2024
Balance Sheet

Genesys Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
31 Mar 2024
Charges

A charge registered on 07 Sep 2017 via Charge ID 100203811 with Others was fully satisfied on 02 Dec 2023. was recorded as a recent event.
02 Dec 2023
Charges

Progress on A charge registered on 29 Oct 2016 via Charge ID 100203812 with Others was fully satisfied on 02 Dec 2023. was documented.
02 Dec 2023
Charges

A charge with State Bank Of India of Rs. 11.00 Cr registered on 03 Aug 2018 with Charge ID 100200402 was modified on 31 Mar 2023. was recorded as a recent event.
31 Mar 2023

Explore recent activity and updates - View Recent Activity